MeSH tree: E02.095.465.425.400.330.050.400
Chimeric Antigen Receptor (CAR) T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain ...
Nov 4, 2025
0
31
Melanoma, the deadliest form of skin cancer, can't always be removed with a scalpel.
Oct 28, 2025
0
17
An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding interleukin 12 strategy that lets CAR-T cells treat prostate cancer in mice while curbing previously ...
For a little over two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a powerful new way to treat cancer. By extracting patients' T cells, re-engineering them to recognize tumor antigens, and infusing ...
Oct 24, 2025
0
52
The European Society for Blood and Marrow Transplantation (EBMT) has released its ninth special report on indications for hematopoietic cell transplantation (HCT) and chimeric antigen receptor T-cell (CAR-T) therapy. The ...
Oct 2, 2025
0
13
Chimeric antigen receptor (CAR) T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have struggled to adapt the ...
Oct 1, 2025
0
63
Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the United States. Despite recent advances, the 5-year survival rate for metastatic UC remains about 5% to ...
Sep 10, 2025
0
23
Peking University scientists have developed a cancer therapy that could make life-saving treatment accessible to any patient, anywhere. A team led by Professor Wei Wensheng from Peking University, collaborating with the PLA ...
Sep 8, 2025
0
41
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with ...
Sep 3, 2025
0
12
A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing in pediatric high-grade glioma tumors but not in normal brain tissues. Preclinical research ...
Aug 15, 2025
0
100
